Trans-Aortic Percutaneous Heart Valve Deployment of Impella CPTM to Assist in High-Risk Percutaneous Coronary Intervention - 07/05/14
Doi : 10.1016/j.hlc.2013.12.012
William Chan, MBBS, PhD ⁎ 
, Peter H. Seidelin, MBChB, MD
, Peter H. Seidelin, MBChB, MD Division of Cardiology, Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
?Corresponding author at: University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario, M5G 2C4, Canada. Tel.: +416 340-4930; fax: +416 340-3865.
Keywords : Aortic stenosis, Transcatheter aortic valve implant, Impella CP, Left main, Percutaneous coronary intervention, In-stent restenosis
Esquema
© 2014
Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 23 - N° 5
P. e142-e144 - mai 2014 Regresar al número
Artículo precedente
- Type A Aortic Dissection Secondary to Ruptured Penetrating Ascending Aortic Ulcer in an Immunosuppressed Patient
- Vinesh Appadurai, Ahmad Al-Hindawi, Paul Leschke, Kim Greaves
- Primary Cardiac Angiosarcoma with Pulmonary and Lumbar Metastases Presenting as Unexplained Pericardial Effusion in a 41 Year-old Man
- Yijun Dong, Da Zhu, Li Dong, Li Ren
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?